Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Apr 3;14(4):864-867.
doi: 10.1080/21645515.2017.1409317. Epub 2017 Dec 21.

Voluntary termination of pregnancy: An opportunity for Measles, Mumps and Rubella vaccination in an Italian healthcare local unit

Affiliations

Voluntary termination of pregnancy: An opportunity for Measles, Mumps and Rubella vaccination in an Italian healthcare local unit

V Pettinicchio et al. Hum Vaccin Immunother. .

Abstract

In Italy, the National Plan for the Elimination of Measles and Congenital Rubella 2010-15 suggests offering Measles, Mumps and Rubella (MMR) vaccination to susceptible women who underwent voluntary termination of pregnancy (VTP) In Rome, S. Eugenio Hospital is one of the structures where VTP is practised in an Operative Unit called "Family Planning" The primary goal of this study was to estimate the prevalence of susceptibility to rubella, using IgG and IgM immunoassays, among women accessing VTP and to offering MMR vaccination to susceptible women. Secondarily, this study evaluated acceptance of the vaccination offer From 2013 to 2015, data were collected from 1513 voluntary termination of pregnancy (VTP) cases The results show a significant increase of 5 percent in susceptibility prevalence in the target group from 13.6% in 2013 and 2014 to 18.4% in 2015 The association between rubella susceptibility and age was statistically significant (p<0.01) Throughout the entire period, acceptance of the vaccine proposal was 19% (45/232) among susceptible women; 58% (135/232) refused the vaccine and 23% (52/232) took time to think about it This study shows an increase of 5 percent in the prevalence of rubella susceptibility over two years. This result is worrying, even considering the short span of the data collection The rate of acceptance of vaccination is unsatisfactory considering the possibility of future pregnancies This issue deserves continued action, which, going forward, might transform a "project" into a shared strategy as part of a wider network with the goal of aligning Italy with international recommendations.

Keywords: Active offering; MMR vaccine; immunization programs; rubella; voluntary interruption of pregnancy.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Women who performed a Rubella test by age and proportion of susceptible; data from Family Planning Unit, S. Eugenio Hospital (2014–15, n. 1190).
Figure 2.
Figure 2.
Women who accepted to be vaccinated by age; data from Family Planning Unit, S. Eugenio Hospital (2014–15).

References

    1. “The Global Vaccine Action Plan 2011–2020 ”, WHO 2012. http://www.who.int/immunization/global_vaccine_action_plan/GVAP_doc_2011...
    1. “European Vaccine Action Plan 2015–2020 ”, WHO, 2014. http://www.euro.who.int/en/health-topics/communicablediseases/hepatitis/....
    1. “4th Meeting of the European Regional Verification Commission for Measles and Rubella Elimination (Rvc) ”, WHO 2015. http://www.euro.who.int/en/health-topics/communicable-diseases/measles-a....
    1. European Commission Commission Implementing Decision of 8 August 2012 (2012/506/EU) amending Decision 2002/253/EC laying down case definitions for reporting communicable diseases to the Community network under Decision No 2119/98/EC of the European Parliament and of the Council. Official J Eur Union. Luxembourg: Publications Office Eur Union. 27.9.2012;L 262 http://eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX%3A32012D0506.
    1. Giambi C, Bella A, Filia A, Del Manso M, Nacca G, Declich S, Rota MC; Regional contact points for rubella. Underreporting of congenital rubella in Italy, 2010–2014. Eur J Pediatr. 2017;176(7):955–962. doi:10.1007/s00431-017-2935-7. PMID:28551878. - DOI - PubMed

Substances

LinkOut - more resources